 to 1 year with the Gore carotid stent (W. L.
Gore & Associates). The trial enrolled 312 patients, but
only 265 were included in the primary analysis. Thirtyday mortality risk was 0.6% (out of 265) and 30-day stroke
risk was 2.9% in the entire cohort. The two deaths reported in the study were not stroke related.

62S

Journal